Edgewise Therapeutics Inc (EWTX)
33.88
-0.12
(-0.35%)
USD |
NASDAQ |
Nov 04, 13:04
Edgewise Therapeutics 1 Year Total Returns (Daily): 427.1% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 427.1% |
October 31, 2024 | 424.5% |
October 30, 2024 | 387.8% |
October 29, 2024 | 451.2% |
October 28, 2024 | 444.6% |
October 25, 2024 | 419.8% |
October 24, 2024 | 398.1% |
October 23, 2024 | 417.2% |
October 22, 2024 | 404.0% |
October 21, 2024 | 410.2% |
October 18, 2024 | 392.7% |
October 17, 2024 | 392.5% |
October 16, 2024 | 406.2% |
October 15, 2024 | 391.7% |
October 14, 2024 | 374.2% |
October 11, 2024 | 366.0% |
October 10, 2024 | 317.1% |
October 09, 2024 | 350.7% |
October 08, 2024 | 302.4% |
October 07, 2024 | 290.0% |
October 04, 2024 | 372.5% |
October 03, 2024 | 357.6% |
October 02, 2024 | 372.4% |
October 01, 2024 | 376.6% |
September 30, 2024 | 365.8% |
Date | Value |
---|---|
September 27, 2024 | 327.7% |
September 26, 2024 | 325.4% |
September 25, 2024 | 337.0% |
September 24, 2024 | 332.7% |
September 23, 2024 | 342.2% |
September 20, 2024 | 356.1% |
September 19, 2024 | 378.1% |
September 18, 2024 | 201.3% |
September 17, 2024 | 181.5% |
September 16, 2024 | 162.6% |
September 13, 2024 | 195.6% |
September 12, 2024 | 167.0% |
September 11, 2024 | 157.6% |
September 10, 2024 | 175.4% |
September 09, 2024 | 180.7% |
September 06, 2024 | 170.0% |
September 05, 2024 | 167.5% |
September 04, 2024 | 178.0% |
September 03, 2024 | 177.2% |
August 30, 2024 | 203.4% |
August 29, 2024 | 172.1% |
August 28, 2024 | 172.8% |
August 27, 2024 | 177.4% |
August 26, 2024 | 183.2% |
August 23, 2024 | 165.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.50%
Minimum
May 25 2022
451.2%
Maximum
Oct 29 2024
28.41%
Average
-25.27%
Median
Jul 12 2023
1 Year Total Returns (Daily) Benchmarks
Catalyst Pharmaceuticals Inc | 73.18% |
Vertex Pharmaceuticals Inc | 27.56% |
Sarepta Therapeutics Inc | 61.12% |
Regenxbio Inc | -38.06% |
Entrada Therapeutics Inc | 13.55% |